Literature DB >> 8960941

Pathology of fatal perioperative myocardial infarction: implications regarding pathophysiology and prevention.

M M Dawood1, D K Gutpa, J Southern, A Walia, J B Atkinson, K A Eagle.   

Abstract

The aim of this study was to determine the pathology of fatal postoperative myocardial infarction (MI) and compare it with that of non-operative myocardial infarction. Histopathological analyses of coronary arteries and myocardium were performed on autopsy heart specimens (n = 67), and clinical attributes were studied. Findings of perioperative MI (n = 42) were compared to those of non-perioperative MI (n = 25). Significant atherosclerotic obstruction (> 50% cross-sectional narrowing) was observed in the majority of patients (93%). Left main (> 50% cross-sectional narrowing) and/or three-vessel coronary artery disease were especially common (44%) in this group. Evidence of unstable plaques with disruption was noted in 55% of perioperative MI patients (n = 23); plaque hemorrhage was found in 45% (n = 19). Predicting the site of infarction based on severity of underlying stenosis would have been unsuccessful in more than half the patients in both perioperative and nonoperative MI groups. Clinical profiles of the patients in the two groups were similar in terms of prior cardiac history, gender and age. Fatal perioperative MI occurs predominantly in patients with multivessel coronary disease, especially left main and three-vessel disease. The severity of preexisting underlying stenosis did not predict the resulting infarct territory. Evidence of acute plaque disruption in the infarct-related artery is common. Perioperative MIs have similar coronary artery pathology to non-operative MIs with regard to coronary plaque hemorrhage, rupture, and thrombus formation and probably occur by a similar mechanism.

Entities:  

Mesh:

Year:  1996        PMID: 8960941     DOI: 10.1016/s0167-5273(96)02769-6

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  34 in total

Review 1.  Acp. Best practice no 155. Pathological investigation of deaths following surgery, anaesthesia, and medical procedures.

Authors:  R D Start; S S Cross
Journal:  J Clin Pathol       Date:  1999-09       Impact factor: 3.411

Review 2.  [Non-opioid analgesics for perioperative pain therapy. Risks and rational basis for use].

Authors:  A Brack; H L Rittner; M Schäfer
Journal:  Anaesthesist       Date:  2004-03       Impact factor: 1.041

Review 3.  [Perioperative beta-receptor blockade. For and against].

Authors:  B Preckel; M Poels; F Wappler; W Schlack; W Buhre
Journal:  Anaesthesist       Date:  2010-07       Impact factor: 1.041

Review 4.  [Current aspects of anesthetic management in urological patients].

Authors:  O Groll; J Peters
Journal:  Urologe A       Date:  2010-09       Impact factor: 0.639

Review 5.  Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk.

Authors:  P J Devereaux; Lee Goldman; Deborah J Cook; Ken Gilbert; Kate Leslie; Gordon H Guyatt
Journal:  CMAJ       Date:  2005-09-13       Impact factor: 8.262

Review 6.  [Strategies for perioperative sympatho-modulation].

Authors:  J Wacker; T Pasch; M C Schaub; M Zaugg
Journal:  Anaesthesist       Date:  2005-04       Impact factor: 1.041

Review 7.  Managing patients undergoing non-cardiac surgery: need to shift emphasis from risk stratification to risk modification.

Authors:  G Karthikeyan; B Bhargava
Journal:  Heart       Date:  2006-01       Impact factor: 5.994

Review 8.  Preoperative cardiac testing before major vascular surgery.

Authors:  Sanne E Hoeks; Olaf Schouten; Maureen J van der Vlugt; Don Poldermans
Journal:  J Nucl Cardiol       Date:  2007 Nov-Dec       Impact factor: 5.952

Review 9.  Perioperative organ injury.

Authors:  Karsten Bartels; Jörn Karhausen; Eric T Clambey; Almut Grenz; Holger K Eltzschig
Journal:  Anesthesiology       Date:  2013-12       Impact factor: 7.892

10.  Treatment recommendations to prevent myocardial ischemia and infarction in patients undergoing vascular surgery.

Authors:  Willem-Jan Flu; Sanne E Hoeks; Jan-Peter van Kuijk; Jeroen J Bax; Don Poldermans
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.